H.R. 9192 · 119th Congress · Health

Prior Authorization Reform for Autoimmune and Blood Disorders Act

In committee849 words Introduced Jun 8, 2026 · Latest action Jun 8, 2026

How far it has goneStage 2 of 6
  1. IntroducedJun 8, 2026 Done
  2. CommitteeReferred to 3 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

2 organizations, more than 78% of House bills · 4 filings · Q2 2026–Q3 2026

See which of this bill’s sponsors and cosponsors got money from the lobbying organizations’ PACs → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Medical Association 2 of 2 quarters
    “…H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.929 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions H.R.9393 - Lower Costs, More Transparency Act of 2026, all provisions H.R.9396 - Prior Authorization Accountability Act, all…”

    $17.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  2. American College of Rheumatology 2 of 2 quarters
    “…HR 9192 Patient Access to Autoimmune Treatments ActᅠHR 5467 Patients First Act H.R. 9693 Expedited Access to Biosimilars Act H.R. 9661/ S. 1414 Protecting Approved Care Act H.R. 10394 Doctors Not AI Act of 2026 H.R. 10210 Protecting Patients from Automatic Denials Act H.R. 9734”

    $270K lobbying spend in 2026 to date, all issuesQ3 2026 filing

Organizations that named H.R. 9192 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jun 8, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Jun 8, 2026Introduced in House

What members said about it

  • Statement · Press release · Sep 30, 2026 · Bresnahan R-PA

    Bresnahan Pushes for Prior Authorization Reform in Congress

    Today, U.S. Representative Rob Bresnahan, Jr. (PA-08) announced that he cosponsored several pieces of legislation targeted at improving accountability from insurance companies and protect patients from unnecessary delays in care.

    “Insurance companies have a responsibility to manage healthcare costs, but that should never mean putting profits ahead of patients.”